Lv Guixiang, Hu Zheng, Tie Yi, Du Jingli, Fu Hanjiang, Gao Xu, Zheng Xiaofei
Beijing Institute of Radiation Medicine, Beijing 100850, P.R. China.
Department of Pathology, General Hospital of PLA, Beijing 100853, P.R. China.
Oncol Rep. 2014 Sep;32(3):1021-8. doi: 10.3892/or.2014.3296. Epub 2014 Jun 27.
Accumulating evidence suggests that microRNAs (miRNAs) can function as oncogenes or as tumor suppressor genes depending on the tissue type or target. Therefore, clarification of the specific roles of miRNAs is vital for the diagnosis and treatment of cancer. In the present study, miR-451 was found to be downregulated in hepatocellular carcinoma (HCC) tissues when compared to that in adjacent tissues. Functional analysis showed that, in vitro, miR-451 inhibited the migration of hepatoma cell lines HepG2 and SK-Hep-1. Further investigation of the molecular mechanisms identified activating transcription factor 2 (ATF2) as a target of miR-451. miR-451 inhibited ATF2 expression by binding to the 3'UTR. An in vivo assay revealed a significant negative correlation between miR-451 and ATF2 in liver cancer tissues. According to previous findings reported in the literature, the opposing functions of ATF2 are related to its subcellular localization. In the nucleus, ATF2 displays oncogenic activities in melanoma. In the present study, ATF2 exhibited a higher expression level in the nucleus in tumoral tissues of HCC as detected by immunohistochemistry. In conclusion, in this study, we identified a potential target of miR-451, ATF2, and revealed a novel role of miR-451 in the inhibition of the migratory ability of hepatoma cell lines.
越来越多的证据表明,微小RNA(miRNA)可根据组织类型或靶标发挥癌基因或肿瘤抑制基因的作用。因此,阐明miRNA的具体作用对于癌症的诊断和治疗至关重要。在本研究中,与癌旁组织相比,发现miR-451在肝细胞癌(HCC)组织中表达下调。功能分析表明,在体外,miR-451抑制肝癌细胞系HepG2和SK-Hep-1的迁移。对分子机制的进一步研究确定激活转录因子2(ATF2)是miR-451的靶标。miR-451通过与3'非翻译区(3'UTR)结合抑制ATF2表达。体内实验显示肝癌组织中miR-451与ATF2之间存在显著负相关。根据文献报道的先前研究结果,ATF2的相反功能与其亚细胞定位有关。在细胞核中,ATF2在黑色素瘤中表现出致癌活性。在本研究中,通过免疫组织化学检测发现,在HCC肿瘤组织中,ATF2在细胞核中的表达水平较高。总之,在本研究中,我们鉴定了miR-451的潜在靶标ATF2,并揭示了miR-451在抑制肝癌细胞系迁移能力方面的新作用。